Related references
Note: Only part of the references are listed.Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores
Martin Hoenigl
CLINICAL INFECTIOUS DISEASES (2021)
A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit
P. Lewis White et al.
CLINICAL INFECTIOUS DISEASES (2021)
Concerning P450 Evolution: Structural Analyses Support Bacterial Origin of Sterol 14α-Demethylases
David C. Lamb et al.
MOLECULAR BIOLOGY AND EVOLUTION (2021)
Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design
Brian C. Monk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018
Shawn A. Messer et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation AgainstCandida albicans
Faizah A. Binjubair et al.
CHEMMEDCHEM (2020)
Hybridization Facilitates Adaptive Evolution in Two Major Fungal Pathogens
Himeshi Samarasinghe et al.
GENES (2020)
Threats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture
Matthew C. Fisher et al.
MBIO (2020)
Intestinal fungi are causally implicated in microbiome assembly and immune development in mice
Erik van Tilburg Bernardes et al.
NATURE COMMUNICATIONS (2020)
Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates
Yongqin Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Potent arylamide derivatives as dual-target antifungal agents: Design, synthesis, biological evaluation, and molecular docking studies
Yue Dong et al.
BIOORGANIC CHEMISTRY (2020)
Regulation of Ergosterol Biosynthesis inSaccharomyces cerevisiae
Tania Jorda et al.
GENES (2020)
A requirement for an active proton delivery network supports a compound I-mediated C?C bond cleavage in CYP51 catalysis
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Review of the Novel Investigational Antifungal Olorofim
Nathan P. Wiederhold
JOURNAL OF FUNGI (2020)
Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols
Nicolas Lebouvier et al.
PHARMACEUTICALS (2020)
Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinic et al.
DRUG RESISTANCE UPDATES (2020)
An Erg11 lanosterol 14-α-demethylase-Arv1 complex is required forCandida albicansvirulence
Michelle L. Villasmil et al.
PLOS ONE (2020)
Molecular Dynamics Investigations of Binding Mechanism for Triazoles Inhibitors to CYP51
Na Shi et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Design, synthesis, antifungal activity, and QM/MM docking study of two azole derivatives with indole ring
Suat Sari et al.
JOURNAL OF RESEARCH IN PHARMACY (2020)
The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions
Andrew G. Warrilow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Fungicides: An Overlooked Pesticide Class?
Jochen P. Zubrod et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2019)
Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity
Ben C. Scheele et al.
SCIENCE (2019)
What Your Crystal Structure Will Not Tell You about Enzyme Function
Thomas C. Pochapsky et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Design, synthesis and evaluation of biphenyl imidazole analogues as potent antifungal agents
Shizhen Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Role of Candida albicans mating in genetic variability and adaptation to the host
Ines Correia et al.
FUNGAL BIOLOGY REVIEWS (2019)
Antifungal Agents in Agriculture: Friends and Foes of Public Health
Veronica Soares Brauer et al.
BIOMOLECULES (2019)
Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors
Laura Friggeri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Valley fever on the rise after years of decline in the USA
Roxanne Nelson
LANCET INFECTIOUS DISEASES (2019)
Novel Hit Compounds as Putative Antifungals: The Case of Aspergillus fumigatus
Eftichia Kritsi et al.
MOLECULES (2019)
New diphenylphosphane derivatives of ketoconazole are promising antifungal agents
Rodrigo F. M. de Almeida et al.
SCIENTIFIC REPORTS (2019)
Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161
Brian C. Monk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China
X. Fan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2019)
Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus
Nathan P. Wiederhold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials
David Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway
Yujie Zhou et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51
Shizhen Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Neuroinfections caused by fungi
Katarzyna Goralska et al.
INFECTION (2018)
Sterol 14α-Demethylase Structure-Based Design of VNI ((R)-N-(1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis
Laura Friggeri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
CYP51 as drug targets for fungi and protozoan parasites: past, present and future
Galina I. Lepesheva et al.
PARASITOLOGY (2018)
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Matthew C. Fisher et al.
SCIENCE (2018)
The first isolate of Candida auris in China: clinical and biological aspects
Xiaojuan Wang et al.
EMERGING MICROBES & INFECTIONS (2018)
Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery
Mikhail Keniya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase
Alia A. Sagatova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Present and Future Therapy of Cryptococcus Infections
Ahmad Mourad et al.
JOURNAL OF FUNGI (2018)
Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
Edward Mpoza et al.
MEDICAL MYCOLOGY CASE REPORTS (2018)
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Shawn R. Lockhart et al.
CLINICAL INFECTIOUS DISEASES (2017)
Targeting CYP51 for drug design by the contributions of molecular modeling
Vitor W. Rabelo et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
Fungi in the healthy human gastrointestinal tract
Heather E. Hallen-Adams et al.
VIRULENCE (2017)
Molecular basis of antifungal drug resistance in yeasts
Florent Morio et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Candida auris: An emerging multidrug-resistant pathogen
David Sears et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Revisiting the Metabolism and Bioactivation of Ketoconazole in Human and Mouse Using Liquid Chromatography-Mass Spectrometry-Based Metabolomics
Ju-Hyun Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase
Rita Caramalho et al.
SCIENTIFIC REPORTS (2017)
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Sarah G. Whaley et al.
FRONTIERS IN MICROBIOLOGY (2017)
The gut mycobiome of the Human Microbiome Project healthy cohort
Andrea K. Nash et al.
MICROBIOME (2017)
Substrate recognition by two different P450s: Evidence for conserved roles in a common fold
Drew R. Tietz et al.
SCIENTIFIC REPORTS (2017)
Results from a phase 2, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of VT 1161 oral tablets in the treatment of patients with recurrent vulvovaginal candidiasis
J. D. Sobel et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection
Teclegiorgis Gebremariam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors
Christopher M. Yates et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Forgotten fungi-the gut mycobiome in human health and disease
Chloe E. Huseyin et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity
Tatiana Y. Hargrove et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme
Andrew G. S. Warrilow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Aspergillus fumigatus Intrinsic Fluconazole Resistance Is Due to the Naturally Occurring T301I Substitution in Cyp51Ap
Florencia Leonardelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii
Shawn R. Lockhart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Drivers of emerging fungal diseases of forest trees
Luisa Ghelardini et al.
FOREST ECOLOGY AND MANAGEMENT (2016)
Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
Madeline E. Kavanagh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Toward a Reduced Reliance on Conventional Pesticides in European Agriculture
Jay Ram Lamichhane et al.
PLANT DISEASE (2016)
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase
Jason D. Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance
Kelley R. Healey et al.
NATURE COMMUNICATIONS (2016)
Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance
Sarah Delliere et al.
FRONTIERS IN MICROBIOLOGY (2016)
Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals
Joel D. A. Tyndall et al.
PLOS ONE (2016)
Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14α-demethylase
Alia A. Sagatova et al.
SCIENTIFIC REPORTS (2016)
Ploidy plasticity: a rapid and reversible strategy for adaptation to stress
Judith Berman
FEMS YEAST RESEARCH (2016)
Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14 alpha-Demethylase
Alia A. Sagatova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection
Teclegiorgis Gebremariam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae
Ana Carolina R. Souza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Novel Substrate Specificity and Temperature-Sensitive Activity of Mycosphaerella graminicola CYP51 Supported by the Native NADPH Cytochrome P450 Reductase
Claire L. Price et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
Azole antifungals: 35 years of invasive fungal infection management
David Allen et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Dynamics of CYP51: implications for function and inhibitor design
Xiaofeng Yu et al.
JOURNAL OF MOLECULAR RECOGNITION (2015)
Azole fungicides-understanding resistance mechanisms in agricultural fungal pathogens
Claire L. Price et al.
PEST MANAGEMENT SCIENCE (2015)
How to bolster the antifungal pipeline
David W. Denning et al.
SCIENCE (2015)
Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
Jennifer Riley et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Recent advances in the Zymoseptoria tritici-wheat interaction: insights from pathogenomics
Megan C. McDonald et al.
FRONTIERS IN PLANT SCIENCE (2015)
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Stephanie A. Flowers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Drug safety assessment of oral formulations of ketoconazole
Aditya K. Gupta et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Zebrafish: an animal model for research in veterinary medicine
N. Nowik et al.
POLISH JOURNAL OF VETERINARY SCIENCES (2015)
Fungal Membrane Organization: The Eisosome Concept
Lois M. Douglas et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 68 (2014)
The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
A. G. S. Warrilow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Design and optimization of highly-selective fungal CYP51 inhibitors
William J. Hoekstra et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Mechanism of Inhibition of Estrogen Biosynthesis by Azole Fungicides
Chinaza Egbuta et al.
ENDOCRINOLOGY (2014)
Yeast lipid metabolism at a glance
Lisa Klug et al.
FEMS YEAST RESEARCH (2014)
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
H. Ruth Ashbee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Sensitivity of Phakopsora pachyrhizi towards quinone-outside-inhibitors and demethylation-inhibitors, and corresponding resistance mechanisms
Helena K. Schmitz et al.
PEST MANAGEMENT SCIENCE (2014)
Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer
Brian C. Monk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Prothioconazole and Prothioconazole-Desthio Activities against Candida albicans Sterol 14-α-Demethylase
Josie E. Parker et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)
Overcoming the Limitations of Fragment Merging: Rescuing a Strained Merged Fragment Series Targeting Mycobacterium tuberculosis CYP121
Sean A. Hudson et al.
CHEMMEDCHEM (2013)
Azole resistance in Aspergillus fumigatus: a growing public health concern
Edith Vermeulen et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2013)
Frequency, diagnosis and management of fungal respiratory infections
Gemma E. Hayes et al.
CURRENT OPINION IN PULMONARY MEDICINE (2013)
Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans
Ming-Jie Xiang et al.
FEMS YEAST RESEARCH (2013)
Constraints on the evolution of azole resistance in plant pathogenic fungi
H. J. Cools et al.
PLANT PATHOLOGY (2013)
Update on mechanisms of azole resistance in Mycosphaerella graminicola and implications for future control
Hans J. Cools et al.
PEST MANAGEMENT SCIENCE (2013)
Application of Fragment Screening and Merging to the Discovery of Inhibitors of the Mycobacterium tuberculosis Cytochrome P450 CYP121
Sean A. Hudson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
The Monoamine Oxidase A Inhibitor Clorgyline Is a Broad-Spectrum Inhibitor of Fungal ABC and MFS Transporter Efflux Pump Activities Which Reverses the Azole Resistance of Candida albicans and Candida glabrata Clinical Isolates
Ann R. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus
Masato Tashiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens
Rayko Becher et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2012)
Structural differences between soluble and membrane bound cytochrome P450s
I. G. Denisov et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Emerging fungal threats to animal, plant and ecosystem health
Matthew C. Fisher et al.
NATURE (2012)
Hidden Killers: Human Fungal Infections
Gordon D. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Impact of Recently Emerged Sterol 14α-Demethylase (CYP51) Variants of Mycosphaerella graminicola on Azole Fungicide Sensitivity
Hans J. Cools et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Structural basis for conservation in the CYP51 family
Galina I. Lepesheva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Clinical risk factors for invasive aspergillosis
John W. Baddley
MEDICAL MYCOLOGY (2011)
Multiple mechanisms account for resistance to sterol 14 alpha-demethylation inhibitors in field isolates of Mycosphaerella graminicola
Pierre Leroux et al.
PEST MANAGEMENT SCIENCE (2011)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature
Florent Morio et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation Kinetics
Jonathan Rittle et al.
SCIENCE (2010)
Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
Chiung-Kuang Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Paul E. Verweij et al.
LANCET INFECTIOUS DISEASES (2009)
Analysis of the CYP51 gene and encoded protein in propiconazole-resistant isolates of Mycosphaerella fijiensis
Gloria P. Canas-Gutierrez et al.
PEST MANAGEMENT SCIENCE (2009)
Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
Chiung-Kuang Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
Ulrich M. Zanger et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species
Jesus Guinea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus
Juan Luis Rodriguez-Tudela et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evolutionary history of Phakopsora pachyrhizi (the Asian soybean rust) in Brazil based on nucleotide sequences of the internal transcribed spacer region of the nuclear ribosomal DNA
Maira C. M. Freire et al.
GENETICS AND MOLECULAR BIOLOGY (2008)
Are azole fungicides losing ground against Septoria wheat disease?: Resistance mechanisms in Mycosphaerella graminicola
Hans J. Cools et al.
PEST MANAGEMENT SCIENCE (2008)
Outwitting multidrug resistance to antifungals
Brian C. Monk et al.
SCIENCE (2008)
Sterol-rich plasma membrane domains in fungi
Francisco J. Alvarez et al.
EUKARYOTIC CELL (2007)
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient
Steven D. Westbrook et al.
MEDICAL MYCOLOGY (2007)
Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae
Andrew S. Chau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Structural basis for ligand promiscuity in cytochrome P450 3A4
Marika Ekroos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Aneuploidy and isochromosome formation in drug-resistant Candida albicans
Anna Selmecki et al.
SCIENCE (2006)
Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp.
H Wisplinghoff et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
A systematic study of yeast sterol biosynthetic protein-protein interactions using the split-ubiquitin system
CQ Mo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak
JA Fraser et al.
NATURE (2005)
Epidemics of soybean rust (Phakopsora pachyrhizi) in Brazil and Paraguay from 2001 to 2003
JT Yorinori et al.
PLANT DISEASE (2005)
Targeted gene disruption of the 14-α sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility
E Mellado et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A century of fungicide evolution
PE Russell
JOURNAL OF AGRICULTURAL SCIENCE (2005)
Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil
GH Goldman et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
The ERG28-encoded protein, Erg28p, interacts with both the sterol C-4 demethylation enzyme complex as well as the late biosynthetic protein, the C-24 sterol methyltransferase (Erg6p)
CQ Mo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2004)
Mutations in Saccharomyces cerevisiae sterol C5-desaturase conferring resistance to the CYP51 inhibitor fluconazole
CJ Jackson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
R Hyland et al.
DRUG METABOLISM AND DISPOSITION (2003)
Protein-protein interactions among C-4 demethylation enzymes involved in yeast sterol biosynthesis
C Mo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The genetic basis of fluconazole resistance development in Candida albicans
J Morschhäuser
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Inhibition of cytochromes P450 by antifungal imidazole derivatives
WJ Zhang et al.
DRUG METABOLISM AND DISPOSITION (2002)
Biotransformation reactions of five-membered aromatic heterocyclic rings
DK Dalvie et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2002)
The magnitude of fungal diversity: the 1.5 million species estimate revisited
DL Hawksworth
MYCOLOGICAL RESEARCH (2001)
Design and synthesis of potential inhibitors of the ergosterol biosynthesis as antifungal agents
SK Chung et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Share Paper
